LARS BERTRAM

 

PERSONAL INFORMATION

Position/Title: Head Lübeck Interdisciplinary Platform for Genome Analytics; LIGA), W2 Professor

Address University of Lübeck; Ratzeburger Allee 160, 23538 Lübeck, Germany

Tel: +49-451-31017490; Fax:+49-451-31017494

@: lars.bertram@uni-luebeck.de; www.liga.uni-luebeck.de

 

EDUCATION/POSITIONS

1990-1997 Medical School (Bochum, Strasbourg, Reyjkavik)

1994-1997 Medical Thesis (R.A. Peskar, Department of Pharmacology & Toxicology, Bochum)

1997-1999 Resident, Clinic for Psychiatry and Psychotherapy, Technical University, Munich

1999-2001   Postdoctoral fellow, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, USA

2001-2004   Instructor in Neurology, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, USA

2002-2008   Assistant in Genetics, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, USA

2004-2008   Assistant Professor of Neurology, Harvard Medical School, Boston, MA

2008-2014   Head of Research Group, Max-Planck Institute for Molecular Genetics, Berlin, Germany

2004-2008   Assistant Professor of Neurology, Harvard Medical School, Boston, MA

2004-2008   Assistant Professor of Neurology, Harvard Medical School, Boston, MA

2013-present Reader in Neurogenetics, Imperial College, London, UK

2014-present Professor of Genome Analytics (W2), University of Lübeck, Germany

 

ACADEMIC ACTIVITIES

2007-present Editorial Board of Neurogenetics

2009-present Editorial Board of Int J Mol Epi Genet

2009-present Editorial Board of Eur J Clin Investigation

2010-present Co-speaker Berlin Aging Study II (BASE-II)

2011-present SAB member Alzheimer’s Disease Neuroimaging Initiative (ADNI)

2011-present SAB member AlzBiomarker Database Project

2012-present Editorial Board of Human Mutation

2015-present Editorial Board of Movement Disorders

2015-present SAB member MedBioinformatics Project (funded by H2020)

 

AWARDS

1999 Postdoctoral Research Fellowship of German Research Foundation (DFG)

2001 Fellowship of the Harvard Center for Neurodegeneration and Repair,

Harvard Medical School, Boston, MA

2004 Young Investigator Award, National Alliance for Research on Schizophrenia

and Depression (NARSAD), New York, NY

2009 Independent Investigator Award, NARSAD, New York, NY

2010 Special-Award of the Hans-und-Ilse-Breuer Foundation, Germany

2015 Visiting Professor Scholarship, Chinese Academy of Sciences

 

SELECTED PUBLICATIONS

From 143 original publications; total citations: 11,173; h-index: 42

    1. Bertram L, Blacker D, Mullin K, …, Tanzi RE. Evidence for genetic linkage of Alzheimer’s disease to chromosome 10q. Science 2000;290:2302-2303. (IF: 23.9)
    1. Bertram L, Hiltunen M, Parkinson J, …, Tanzi RE. Family-based association between Alzheimer’s disease and variants in UBQLN1. N Engl J Med 2005;352:884-894. (IF: 44.0)
    1. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE. Systematic Meta-Analyses of Alzheimer’s Disease Genetic Association Studies: The AlzGene Database. Nat Genet 2007;39:17-23. (IF: 25.6)
    1. Allen NC, Bagade S, McQueen MB, …, Bertram L. Systematic Meta-Analyses and Field Synopsis of Genetic Association Studies in Schizophrenia: The SzGene Database. Nat Genet 2008;40:827-834. (IF: 30.3)
    1. Bertram L, Lange C, Mullin K, …, Tanzi RE. Genome-wide association analysis reveals novel Alzheimer’s disease susceptibility loci in addition to APOE. Am J Hum Genet 2008;83:623-32. (IF: 11.2)
    1. Schjeide BMM, Schnack C, Lambert JC, …, Bertram L. The role of CLU, CR1, and PICALM on Alzheimer’s disease risk and CSF biomarker levels. Arch Gen Psychiat 2011;68:207-213. (IF: 12.0)
    1. Lill CM, Roehr JT, McQueen MB, …, Bertram L. Comprehensive research synopsis and systematic meta-analyses in Parkinson’s disease genetics: The PDGene database. PLoS Genet 2012;8:e1002548. (IF: 8.5)
    1. Hooli BV, Mohapatra G, Mattheisen M, …, Bertram L. Role of common and rare APP DNA sequence variants in Alzheimer disease. Neurology 2012;78:1250-1257. (IF: 8.3)
    1. Lill CM, Rengmark A, Pihlstrøm L, Fogh I, …, Bertram L. The role of TREM2 R47H as a risk factor for Alzheimer’s disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson’s disease. Alzheimers Dement 2015 Apr 30. pii: S1552-5260(15)00122-3.[Epub ahead of print] (IF: 12.4)
    1. Hooli BV, Lill CM, Mullin K, …, Bertram L, Tanzi RE. PLD3 gene variants and Alzheimer’s disease. Nature 2015; 520:E7-8. (IF: 41.5)